Literature DB >> 27275360

A Comparison Study of Esophageal Findings on (18)F-FDG PET/CT and Esophagogastroduodenoscopy.

KwanHyeong Jo1, Soyoung Kim1, Jongtae Cha1, Sang Hyun Hwang1, Narae Lee1, Mijin Yun1, Won Jun Kang1.   

Abstract

PURPOSE: The aim of this study was to compare the esophageal findings of 2-deoxy-2-[(18)F]fluoro-d-glucose positron emission tomography-computed tomography ((18)F-FDG PET/CT) and esophagogastroduodenoscopy (EGD).
METHODS: We retrospectively reviewed (18)F-FDG PET/CT and EGD findings of 369 subjects who underwent medical examination between January 2014 and December 2014. The range and intensity of esophageal (18)F-FDG uptake were visually analyzed. The maximum standardized uptake value (SUVmax) of the esophagus and around the esophagogastric (EG) junction was measured. EGD results were provided by the gastroenterologist. We compared the esophageal findings obtained using (18)F-FDG PET/CT and EGD.
RESULTS: There were typical linear FDG uptakes in (18)F-FDG PET/CT patients who underwent EGD the same day. In visual analysis of the range and intensity of the (18)F-FDG uptake, the patients who underwent (18)F-FDG PET/CT and EGD on the same day showed relatively diffuse and discernible (18)F-FDG uptake in the esophagus. Reflux esophagitis was diagnosed in 59 subjects, and 27 of these were classified as higher than Los Angeles classification A. With an increasing degree of reflux esophagitis observed on EGD, the SUVmax in the esophagus and around the EG junction was also increased.
CONCLUSION: Our study showed that FDG uptake at the esophagus or the EG junction might be clinically significantly related to esophagitis. However, EGD performed before (18)F-FDG PET/CT on the same day may affect the esophageal (18)F-FDG uptake.

Entities:  

Keywords:  Esophagogastroduodenoscopy; Esophagus; Physiologic activity; Positron emission tomography; Reflux esophagitis

Year:  2015        PMID: 27275360      PMCID: PMC4870460          DOI: 10.1007/s13139-015-0376-7

Source DB:  PubMed          Journal:  Nucl Med Mol Imaging        ISSN: 1869-3474


  34 in total

1.  Reflux esophagitis secondary to chemotherapy detected by serial FDG-PET.

Authors:  Gonca Gul Bural; Rakesh Kumar; Ayse Mavi; Abass Alavi
Journal:  Clin Nucl Med       Date:  2005-03       Impact factor: 7.794

2.  Whole-body positron emission tomography: normal variations, pitfalls, and technical considerations.

Authors:  B A Gordon; F L Flanagan; F Dehdashti
Journal:  AJR Am J Roentgenol       Date:  1997-12       Impact factor: 3.959

3.  Esophagitis: incidence and risk of esophageal adenocarcinoma--a population-based cohort study.

Authors:  Annmarie Lassen; Jesper Hallas; Ove B Schaffalitzky de Muckadell
Journal:  Am J Gastroenterol       Date:  2006-06       Impact factor: 10.864

4.  Prevalence of gastroesophageal reflux disease in Korea and associated health-care utilization: a national population-based study.

Authors:  Kyoung-Min Kim; Yu Kyung Cho; Seung Jin Bae; Dong-Sook Kim; Ki-Nam Shim; Jie-Hyun Kim; Sung Woo Jung; Nayoung Kim
Journal:  J Gastroenterol Hepatol       Date:  2012-04       Impact factor: 4.029

Review 5.  The natural history of dysplasia and cancer in esophagitis and Barrett esophagus.

Authors:  Stuart Jon Spechler
Journal:  J Clin Gastroenterol       Date:  2003 May-Jun       Impact factor: 3.062

6.  High-definition endoscopy with iScan and Lugol's solution for the detection of inflammation in patients with nonerosive reflux disease: histologic evaluation in comparison with a control group.

Authors:  J W Rey; N Deris; J U Marquardt; T Thomaidis; M Moehler; J M Kittner; M Nguyen-Tat; S Dümcke; A Tresch; S Biesterfeld; M Goetz; J Mudter; M F Neurath; P R Galle; R Kiesslich; A Hoffman
Journal:  Dis Esophagus       Date:  2014-12-17       Impact factor: 3.429

7.  Tumour length measured on PET-CT predicts the most appropriate stage-dependent therapeutic approach in oesophageal cancer.

Authors:  Johannes B Roedl; Dushyant V Sahani; Rivka R Colen; Alan J Fischman; Peter R Mueller; Michael A Blake
Journal:  Eur Radiol       Date:  2008-07-24       Impact factor: 5.315

Review 8.  From reflux esophagitis to Barrett's esophagus and esophageal adenocarcinoma.

Authors:  Rui-Hua Wang
Journal:  World J Gastroenterol       Date:  2015-05-07       Impact factor: 5.742

9.  Reflux esophagitis and its relationship to hiatal hernia.

Authors:  J S Yeom; H J Park; J S Cho; S I Lee; I S Park
Journal:  J Korean Med Sci       Date:  1999-06       Impact factor: 2.153

Review 10.  PET/CT in oncology: for which tumours is it the reference standard?

Authors:  Conor D Collins
Journal:  Cancer Imaging       Date:  2007-10-01       Impact factor: 3.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.